Skip to main content
David Lyden, MD, Pediatric Hematology & Oncology, New York, NY

DavidLydenMD

Pediatric Hematology & Oncology New York, NY

Associate Professor, Pediatrics, Weill Cornell Medical College

Dr. Lyden is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Lyden's full profile

Already have an account?

  • Office

    413 East 69th St
    New York, NY 10021
    Phone+1 212-639-2152

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 1992 - 1995
  • Duke University Hospital
    Duke University HospitalResidency, Pediatrics, 1989 - 1992
  • The Warren Alpert Medical School of Brown University
    The Warren Alpert Medical School of Brown UniversityClass of 1989

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1992 - 2024

Publications & Presentations

PubMed

Journal Articles

  • Complex Polymorphisms in Endocytosis Genes Suggest Alpha-Cyclodextrin as a Treatment for Breast Cancer  
    David Lyden, MD, PLoS One

Press Mentions

  • New Predictors of Metastasis in Patients with Early-Stage Pancreatic Cancer
    New Predictors of Metastasis in Patients with Early-Stage Pancreatic CancerJune 28th, 2024
  • Microscopic Changes in the Liver Can Be Used to Predict Pancreatic Cancer Spread
    Microscopic Changes in the Liver Can Be Used to Predict Pancreatic Cancer SpreadJune 27th, 2024
  • Research Illuminates How Melanoma Readies Lymph Nodes for Tumor Spread
    Research Illuminates How Melanoma Readies Lymph Nodes for Tumor SpreadJanuary 19th, 2022
  • Join now to see all

Grant Support

  • Regulation Of Tumor Angiogenesis By Id+ Marrow PrecursorNational Cancer Institute2003–2006